Search Results - "Smyth, C D"

Refine Results
  1. 1

    Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae by Brunaugh, Ashlee D, Seo, Hyojong, Warnken, Zachary, Ding, Li, Seo, Sang Heui, Smyth, Hugh D C

    Published in PloS one (11-02-2021)
    “…Niclosamide (NIC) has demonstrated promising in vitro antiviral efficacy against SARS-CoV-2, the causative agent of the COVID-19 pandemic. Though NIC is…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Unique and shared inflammatory profiles of human brain endothelia and pericytes by Smyth, Leon C D, Rustenhoven, Justin, Park, Thomas I-H, Schweder, Patrick, Jansson, Deidre, Heppner, Peter A, O'Carroll, Simon J, Mee, Edward W, Faull, Richard L M, Curtis, Maurice, Dragunow, Mike

    Published in Journal of neuroinflammation (11-05-2018)
    “…Pericytes and endothelial cells are critical cellular components of the blood-brain barrier (BBB) and play an important role in neuroinflammation. To date, the…”
    Get full text
    Journal Article
  4. 4

    Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders by Brunaugh, Ashlee D, Wu, Tian, Kanapuram, Sekhar R, Smyth, Hugh D. C

    Published in Molecular pharmaceutics (07-10-2019)
    “…Pulmonary delivery of biopharmaceuticals may enable targeted local therapeutic effect and noninvasive systemic administration. Dry powder inhaler (DPI)…”
    Get full text
    Journal Article
  5. 5

    Excipient-Free Pulmonary Delivery and Macrophage Targeting of Clofazimine via Air Jet Micronization by Brunaugh, Ashlee D, Jan, Syed Umer, Ferrati, Silvia, Smyth, Hugh D. C

    Published in Molecular pharmaceutics (06-11-2017)
    “…Clofazimine (CFZ) is highly active against mycobacterium, including resistant Mycobacterium tuberculosis, but its therapeutic efficacy via the oral route is…”
    Get full text
    Journal Article
  6. 6

    Connectosomes for Direct Molecular Delivery to the Cellular Cytoplasm by Gadok, Avinash K, Busch, David J, Ferrati, Silvia, Li, Brian, Smyth, Hugh D. C, Stachowiak, Jeanne C

    Published in Journal of the American Chemical Society (05-10-2016)
    “…Transport of biomolecules, drugs, and other reagents across the cell’s plasma membrane barrier is an inefficient and poorly controlled process, despite its…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery by Spahn, Jamie E, Hefnawy, Amr, Zhang, Feng, Smyth, Hugh D C

    Published in Pharmaceutics (28-09-2024)
    “…In this study we have developed a high-dose dry powder inhaler formulation of indomethacin using a novel approach to carrier-based formulations. Specifically,…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Controlled Release Pulmonary Administration of Curcumin Using Swellable Biocompatible Microparticles by El-Sherbiny, Ibrahim M, Smyth, Hugh D. C

    Published in Molecular pharmaceutics (06-02-2012)
    “…This study involves a promising approach to achieve sustained pulmonary drug delivery. Dry powder particulate carriers were engineered to allow simultaneous…”
    Get full text
    Journal Article
  11. 11

    Externally controlled triggered-release of drug from PLGA micro and nanoparticles by Hua, Xin, Tan, Shengnan, Bandara, H M H N, Fu, Yujie, Liu, Siguo, Smyth, Hugh D C

    Published in PloS one (05-12-2014)
    “…Biofilm infections are extremely hard to eradicate and controlled, triggered and controlled drug release properties may prolong drug release time. In this…”
    Get full text
    Journal Article
  12. 12

    Identification of a dysfunctional microglial population in human Alzheimer's disease cortex using novel single-cell histology image analysis by Swanson, Molly E V, Scotter, Emma L, Smyth, Leon C D, Murray, Helen C, Ryan, Brigid, Turner, Clinton, Faull, Richard L M, Dragunow, Mike, Curtis, Maurice A

    Published in Acta neuropathologica communications (20-10-2020)
    “…In Alzheimer's disease (AD), microglia are affected by disease processes, but may also drive pathogenesis. AD pathology-associated microglial populations have…”
    Get full text
    Journal Article
  13. 13

    Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) Self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres by El-Sherbiny, Ibrahim M., Smyth, Hugh D.C.

    Published in International journal of pharmaceutics (16-08-2010)
    “…Design of appropriate inhaled carriers with adequate aerodynamic properties, drug release, biodegradation and evasion of macrophage uptake is a major challenge…”
    Get full text
    Journal Article
  14. 14

    The Display of Single-Domain Antibodies on the Surfaces of Connectosomes Enables Gap Junction-Mediated Drug Delivery to Specific Cell Populations by Gadok, Avinash K, Zhao, Chi, Meriwether, Amanda I, Ferrati, Silvia, Rowley, Tanner G, Zoldan, Janet, Smyth, Hugh D. C, Stachowiak, Jeanne C

    Published in Biochemistry (Easton) (09-01-2018)
    “…Gap junctions, transmembrane protein channels that directly connect the cytoplasm of neighboring cells and enable the exchange of molecules between cells, are…”
    Get full text
    Journal Article
  15. 15

    Precision Ocular Drug Delivery Via Aerosol Ring Vortices by Herpin, Matthew J., Smyth, Hugh D. C.

    Published in Pharmaceutical research (01-11-2017)
    “…Purpose Despite being the most prominent dosage form for topical ocular delivery, eye-drops have several well-recognized drawbacks. Addressing these…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms by Du, Ju, Bandara, H. M. H. N, Du, Ping, Huang, Hui, Hoang, Khang, Nguyen, Dang, Mogarala, Sri Vasudha, Smyth, Hugh D. C

    Published in Molecular pharmaceutics (04-05-2015)
    “…The objective of this study was to develop a functionally enhanced antibiotic that would improve the therapeutic activity against bacterial biofilms…”
    Get full text
    Journal Article
  18. 18

    Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments by Zhang, Hairui, Leal, Jasmim, Soto, Melissa R., Smyth, Hugh D. C., Ghosh, Debadyuti

    Published in Pharmaceutics (30-10-2020)
    “…Messenger RNA is a class of promising nucleic acid therapeutics to treat a variety of diseases, including genetic diseases. The development of a stable and…”
    Get full text
    Journal Article
  19. 19

    Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels by Mazzitelli, Jose A., Smyth, Leon C. D., Cross, Kevin A., Dykstra, Taitea, Sun, Jerry, Du, Siling, Mamuladze, Tornike, Smirnov, Igor, Rustenhoven, Justin, Kipnis, Jonathan

    Published in Nature neuroscience (01-05-2022)
    “…It remains unclear how immune cells from skull bone marrow niches are recruited to the meninges. Here we report that cerebrospinal fluid (CSF) accesses skull…”
    Get full text
    Journal Article
  20. 20

    Formulation approaches to short interfering RNA and MicroRNA: challenges and implications by Guzman-Villanueva, Diana, El-Sherbiny, Ibrahim M, Herrera-Ruiz, Dea, Vlassov, Alexander V, Smyth, Hugh D C

    Published in Journal of pharmaceutical sciences (01-11-2012)
    “…RNA interference has emerged as a potentially powerful tool in the treatment of genetic and acquired diseases by delivering short interfering RNA (siRNA) or…”
    Get more information
    Journal Article